Navigation Links
TriReme Medical and Japanese Partner Century Medical, Inc., Receive Shonin Approval for GliderXtreme PTA Catheter in Japan
Date:11/19/2013

PLEASANTON, Calif. and SINGAPORE, Nov. 19, 2013 /PRNewswire/ -- TriReme Medical, LLC. announced today that its Japanese partner, Century Medical, Inc. (CMI), has received Shonin approval for the GliderXtreme™ PTA catheter for the treatment of peripheral arterial blockages, a widespread disease impacting over 200 million people worldwide1. With its low-profile nitinol shaft and proprietary "slide-lock" design, GliderXtreme™ is designed to address complex lesions in the peripheral vasculature. The innovative features of GliderXtreme™ produce a balloon catheter with exceptional pushability and crossability, providing physicians with the confidence needed to begin and finish even the toughest cases.

"Peripheral arterial disease is a growing health care concern in Asia. GliderXtreme™ was custom designed to meet the clinical needs and exacting standards of the Japanese marketplace. We are proud to receive this regulatory approval," stated Eitan Konstantino PhD, President and CEO of TriReme. "This milestone represents yet another step in the Asia-focused expansion strategy of TriReme."

"Representing the latest in peripheral balloon technology, GliderXtreme™ will enable Japanese physicians to treat complex lesions both above and below the knee," explained Akira Hoshino, President and CEO of CMI. "This is the second product approved as a result of our collaboration with TriReme Medical."

About TriReme
Based in Pleasanton, California, TriReme Medical, LLC is a wholly-owned subsidiary of the Singapore based QT Vascular, Ltd. TriReme is dedicated to the development, manufacturing, and commercialization of next generation percutaneous devices for the treatment of complex coronary and peripheral arterial disease.

About Century Medical
Based in Tokyo, Japan, Century Medical, Inc. is a $140 million subsidiary company of ITOCHU Corporation (TSE: ITC) a $115 billion international trading company. Century Medical, Inc., with approx. 300 employees, has a 38 year experience specializing in the importation, sale and marketing of advanced single use and implantable medical devices.

1 Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis; Fowkes et al., The Lancet, Vol 382 October 19, 2013


'/>"/>
SOURCE TriReme Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. TriReme Announces Signing of a Master Distribution Agreement in China
2. TriReme Announces a New Round of Financing Totalling US$18 Million
3. TriReme Medical, Inc. Receives FDA Approval for Glider™ PTCA Catheter
4. Noser Engineering AG Expand Medical Device Technology Offering Meeting the Needs of Global Regulatory Compliance and Accelerating Time to Market
5. Regina E. Dugan Appointed to Board of Directors of Varian Medical Systems
6. Emerging Medical Technologies Spotlight - 2012 Includes 1855 Companies and Is Updated Monthly
7. Medical Device Market Opportunities In France, 2012
8. Medical Device Market Opportunities in Germany, 2012
9. Medical Device Market Opportunities in Mexico, 2012
10. Veran Medical Technologies Welcomes New Member to its Board of Directors
11. China Medical Display Industry Report 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... 2016  The Parenteral Drug Association, Inc. (PDA), ... manufacturing sterile drug products, today announced the publication ... – With link to Comparison Spreadsheet. The ... U.S. FDA, the EU, the Pharmaceutical Inspection Convention/Scheme ... --> --> PDA,s Global Sterile ...
(Date:2/8/2016)... Feb.8, 2016 Cardiovascular Surgery Devices - ... GlobalData,s Medical Devices sector report, "Cardiovascular Surgery Devices ... overview of Cardiovascular Surgery Devices currently in pipeline ... The report provides comprehensive information on the ... at various stages of development. The report reviews ...
(Date:2/8/2016)... FAIRFIELD, N.J. , Feb. 8, 2016  Otsuka ... today announced that they have entered into a licensing ... OPA-15406 in the U.S. and Puerto Rico ... is a topical, non-steroidal phosphodiesterase IV (PDE-4) inhibitor, a ... --> --> In a Phase II ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... Stephanie Hebert Insurance ... beginning of a new charity campaign. As part of their ongoing community involvement ... In the belief that children deserve a voice, and in the spirit of ...
(Date:2/8/2016)... ... February 08, 2016 , ... Tingley ... into Canada to provide its range of unique and advantaged protective solutions ... City that will provide bilingual customer service and marketing support. A new distribution ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... announced today that nominations will be accepted February 8, 2016 through May ... , Awards include the Information Security Executive® of the Year, which recognizes ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort with substantially ... to make a change in public health,” states Carole Baggerly, Director of GrassrootsHealth, ...
(Date:2/8/2016)... ... February 08, 2016 , ... The schedule is now online ... AutismOne 2016 Conference, which is being held May 25-29 at the Loews Chicago O’Hare ... helpful interventions and causes of chronic illness in children. , Very recent articles have ...
Breaking Medicine News(10 mins):